Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Genetic Variants in Stroke

Study ID: NCT07186517
Start Date: 2025-10-01
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

Windmills Hospital

Source: clinicaltrials.gov

Share:
Add to list

Study of CHO-A04 in Advanced Solid Tumors

Study ID: NCT07049458
Start Date: 2025-12-01
End Date: 2028-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

62

Intervention / Treatment

Cho-A04

Sponsor

Quit Farma Nis.

Source: clinicaltrials.gov

Share:
Add to list

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada

Study ID: NCT07189858
Start Date: 2025-10-06
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

4740

Intervention / Treatment

Nasal antimicrobial photodisinfection therapy

Sponsor

Ondine Biomedical Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Study ID: NCT07161414
Start Date: 2025-10-21
End Date: 2028-03-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

IV Rilvegostomig

Recombinant Human Hyaluronidase (rHu)

SC Rilvegostomig

SC rilvegostomig + rHu

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV

Study ID: NCT06507917
Start Date: 2025-10-01
End Date: 2026-11-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

398

Intervention / Treatment

anal swabbing

Sponsor

Reunion university hospital center

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Slow Release DHEA

Study ID: NCT07179952
Start Date: 2025-10-01
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Slow Release DHEA

Placebo

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).

Study ID: NCT07191249
Start Date: 2025-10-10
End Date: 2029-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Mosunetuzumab is a bispecific monoclonal antibody targeting CD20 on B cells and CD3 on T cells, redirecting T cells to eliminate malignant B cells.

Sponsor

Tel-Aviv Sourasky Medical Center

Source: clinicaltrials.gov

Share:
Add to list

129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation

Study ID: NCT07192016
Start Date: 2026-03
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase4

No. of Participants

60

Intervention / Treatment

fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg

Sponsor

Western University, Canada

Source: clinicaltrials.gov

Share:
Add to list

Posture Training for Middle Schoolers

Study ID: NCT06909747
Start Date: 2025-10-15
End Date: 2026-03-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Posture Training

Sponsor

Amasya University

Source: clinicaltrials.gov

Share:
Add to list

Globus Reflect Tether - HUD

Study ID: NCT06521814
Start Date: 2025-11-01
End Date: 2033-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

REFLECT scoliosis correction system

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list